Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens usingEscherichia Coli-asparaginase orErwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)-Reference-Cited by-同舟云学术

Minimal residual disease (MRD) measurement as a tool to compare the efficacy of chemotherapeutic drug regimens usingEscherichia Coli-asparaginase orErwinia-asparaginase in childhood acute lymphoblastic leukemia (ALL)

Published:2006 Issue:3 Volume:47 Page:299-304
ISSN:1545-5009
Container-title:Pediatric Blood & Cancer
language:en
Short-container-title:Pediatr. Blood Cancer

Author:

Kwok Cecilia Sze,Kham Shirley Kow,Ariffin Hany,Lin Hai Peng,Quah Thuan Chong,Yeoh Allen Eng

Publisher

Wiley

Subject

Oncology,Hematology,Pediatrics, Perinatology and Child Health

Reference28 articles.

1. Childhood acute lymphoblastic leukaemia – current status and future perspectives

2. Evidence that the L-Asparaginase Activity of Guinea Pig Serum is responsible for its Antilymphoma Effects

3. Long-term results of three randomized trials (58831, 58832, 58881) in childhood acute lymphoblastic leukemia: a CLCG-EORTC report

4. Children's Cancer Group trials in childhood acute lymphoblastic leukemia: 1983–1995

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preclinical evaluation of engineered L-asparaginase variants to improve the treatment of Acute Lymphoblastic Leukemia;Translational Oncology;2024-05

2. Back to the future: the amazing journey of the therapeutic antileukemia enzyme asparaginase <i>Erwinia chrysanthemi</i>;Haematologica;2023-07-20

3. Experience with Generic Pegylated L-asparaginase in Children with Acute Lymphoblastic Leukemia from a Tertiary Care Oncology Center in South India;South Asian Journal of Cancer;2023-04-10

4. Amino acid deprivation using enzymes as a targeted therapy for cancer and viral infections;Expert Opinion on Therapeutic Patents;2016-11-15

5. Population pharmacokinetics of intravenous Erwinia asparaginase in pediatric acute lymphoblastic leukemia patients;Haematologica;2016-11-10